What is Transcarent?
Founded in 2018 and headquartered in San Francisco, California, Transcarent operates as a comprehensive health and care platform. It is designed to connect employees of self-insured employers and their families with crucial information and expert advisors to support informed medical decision-making. The platform aims to simplify complex healthcare navigation, providing clarity and guidance for individuals seeking optimal care pathways. Transcarent's approach focuses on empowering users with the knowledge and resources necessary to manage their health effectively, thereby enhancing the overall healthcare experience for its members.
How much funding has Transcarent raised?
Transcarent has raised a total of $424M across 4 funding rounds:
Series A
$40M
Series B
$58M
Series C
$200M
Series D
$126M
Series A (2020): $40M with participation from General Catalyst, Alta Partners, and 7wireVentures
Series B (2021): $58M led by General Catalyst, 7wireVentures, Merck Global Health Innovation Fund, and Kleiner Perkins
Series C (2022): $200M supported by Kinnevik and The Human Capital Institute
Series D (2024): $126M featuring General Catalyst and 7wireVentures
Key Investors in Transcarent
General Catalyst
General Catalyst is a venture capital firm that supports transformational business opportunities across multiple sectors and stages, focusing on backing entrepreneurs with ambitious visions to reshape industries. They provide strategic capital and operational support to accelerate growth and build enduring enterprises.
7wireVentures
7wireVentures invests in early-stage digital health companies focused on creating informed and connected health consumers, aiming to revolutionize healthcare through innovative solutions and personalized coaching.
Kinnevik
Kinnevik is an investment company focused on building digital consumer businesses, partnering with founders to create and lead fast-growing companies that deliver both shareholder and social value.
What's next for Transcarent?
With the recent infusion of $126M in a major strategic investment, Transcarent is poised for accelerated growth and market penetration. This significant capital backing, part of its $424M in total financing, will likely be directed towards enhancing its platform capabilities, expanding its service offerings, and broadening its reach to more self-insured employers and their employees. The company's focus on simplifying healthcare decisions and connecting users with expert advice positions it to capitalize on the increasing demand for transparent and patient-centric healthcare solutions. Future developments may include further integration of advanced technologies and strategic partnerships to solidify its position as a leader in the digital health landscape.
See full Transcarent company page
